EUVIMEDEUVIMED entdecken
CrossrefInfokarte

UPLC‐MS/MS‐Based Analysis of the Impact of Polypharmacy on Quetiapine Plasma Concentrations

Qiangli Qi, Qian Wang, Shuaimin Jiang, Tian He, Wei Li, Xiaojie Tan, Wen Li

Biomedical Chromatography · 2026-12 · 40 (12)

DOI: 10.1002/bmc.70651 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Quetiapine, a second‐generation atypical antipsychotic, has broad indications and considerable variation in daily prescribed doses across different diseases, yet its therapeutic window remains narrow (100–500 ng/mL). In clinical practice, quetiapine is frequently co‐administered with other psychotropic drugs. To evaluate the impact of commonly co‐administered medications on quetiapine plasma concentrations, we developed and validated a rapid and sensitive ultra‐performance liquid chromatography–tandem mass spectrometry (UPLC‐MS/MS) method for the simultaneous quantification of quetiapine and 16 commonly co‐administered psychotropic drugs in human plasma. Method validation demonstrated good linearity for all analytes, with precision (CV < 15%), accuracy (85%–115%), and extraction recovery (85%–115%) meeting acceptance criteria. Matrix effects were negligible, and no significant carryover or interference was observed. Results revealed complex polypharmacy regimens within the cohort, with up to six psychotropic drugs co‐administered with quetiapine. Among the 16 subjects, 56.2% exhibited subtherapeutic quetiapine concentrations (< 100 ng/mL), more frequent in patients co‐administered with alprazolam or mirtazapine. It is therefore speculated that alprazolam, mirtazapine, and related agents may influence quetiapine systemic exposure. Clinically, when co‐administered with these agents, quetiapine plasma concentrations should be monitored regularly to ensure efficacy and safety.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →